Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Completes Seahorse Bio Acquisition

NEW YORK (GenomeWeb) – Agilent Technologies today announced the completion of its acquisition of Seahorse Bioscience.

Agilent said in a statement that Seahorse's technology for measuring cell metabolism and bioenergetics complements Agilent's separations and mass spectrometry business. The approximately 200 Seahorse employees are now a part of the Mass Spectrometry Division of the Life Sciences and Applied Markets Group.

Agilent did not disclose the final purchase price; however, it announced a definitive agreement to buy Billerica, Massachusetts-based Seahorse in September, for $235 million in cash.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.